Shopping Cart
- Remove All
- Your shopping cart is currently empty
ROCK2 inhibitor is a chemical compound associated with the therapeutic management of psoriasis. It exhibits its efficacy in targeting ROCK2 enzymes within HaCaT cells and has demonstrated beneficial effects in a psoriasis-like mouse model.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | 8-10 weeks | |
50 mg | Inquiry | 8-10 weeks |
Description | ROCK2 inhibitor is a chemical compound associated with the therapeutic management of psoriasis. It exhibits its efficacy in targeting ROCK2 enzymes within HaCaT cells and has demonstrated beneficial effects in a psoriasis-like mouse model. |
In vitro | ROCK2-IN-7 (2-5$, 24 hours) inhibits the ROCK2/pSTAT3 signaling pathway in HaCaT cells [1]. |
In vivo | ROCK2-IN-7 administration (20-80 mg/kg, oral, daily for 7 days) reduced key interleukins associated with the IL-23/Th17 axis and important factors involved in keratinocyte proliferation [1]. Concurrently, ROCK2-IN-79 (20-80 mg/kg, oral, daily for 7 days) inhibited systemic immune activation, alleviating inflammation [1]. |
Molecular Weight | 445.53 |
Formula | C26H28FN5O |
Cas No. | 3000541-95-4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.